Sciencast Management LP Takes Position in Option Care Health, Inc. (NASDAQ:OPCH)

Sciencast Management LP purchased a new position in Option Care Health, Inc. (NASDAQ:OPCH) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 36,867 shares of the company’s stock, valued at approximately $855,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in OPCH. UMB Bank n.a. raised its stake in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after acquiring an additional 346 shares during the period. Signaturefd LLC grew its holdings in Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after purchasing an additional 1,005 shares during the last quarter. Quarry LP raised its position in Option Care Health by 327.7% in the 3rd quarter. Quarry LP now owns 3,430 shares of the company’s stock worth $107,000 after purchasing an additional 2,628 shares during the period. Blue Trust Inc. raised its position in Option Care Health by 16.9% in the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock worth $109,000 after purchasing an additional 681 shares during the period. Finally, Venturi Wealth Management LLC raised its position in Option Care Health by 2,621.3% in the 4th quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company’s stock worth $110,000 after purchasing an additional 4,561 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Performance

Shares of NASDAQ:OPCH opened at $34.58 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm’s 50 day simple moving average is $31.84 and its 200-day simple moving average is $28.32. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $34.85. The firm has a market cap of $5.72 billion, a PE ratio of 29.06, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33.

Insider Activity

In other news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on OPCH shares. Barrington Research increased their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research report on Thursday, February 27th. JPMorgan Chase & Co. increased their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research report on Thursday, March 6th. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and increased their price objective for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. JMP Securities reissued a “market outperform” rating and issued a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Finally, UBS Group started coverage on shares of Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 target price on the stock. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $33.00.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.